Unexplained weight loss, medically termed as 'involuntary weight loss' (IWL), is a common yet perplexing clinical scenario that often poses significant diagnostic challenges. It is defined as a loss of more than 5% of body weight over a period of 6 to 12 months without an apparent cause. This article aims to provide a comprehensive approach to evaluating unexplained weight loss in clinical practice.
The initial assessment should involve a thorough history and physical examination, focusing on dietary intake, physical activity, psychological status, and medication use. The presence of associated symptoms such as anorexia, dysphagia, or gastrointestinal symptoms may provide clues to the underlying cause.
Basic laboratory investigations should include a complete blood count, basic metabolic panel, liver function tests, thyroid function tests, and inflammatory markers. If initial tests are unremarkable, further investigations such as endoscopy, imaging studies, or specialized blood tests may be warranted based on clinical suspicion.
Imaging studies play a crucial role in evaluating unexplained weight loss. Abdominal ultrasound, CT scan, or MRI may be used to identify potential malignancies, chronic infections, or metabolic disorders. PET scan may be considered in patients with high suspicion of malignancy but negative initial workup.
The management of unexplained weight loss is directed at the underlying cause. In cases where no cause is identified, a symptom-focused approach may be adopted, including nutritional support and psychological intervention.
In conclusion, unexplained weight loss is a complex clinical entity requiring a systematic and comprehensive approach for evaluation. The aim should be to identify treatable causes and to provide supportive care in cases where no underlying cause can be found. Further research is needed to develop more effective diagnostic algorithms and management strategies for this challenging clinical scenario.
1.
Toward rapid and comprehensive genetic diagnosis of pediatric cancer through adaptive sequencing
2.
Q&A: Why adolescents and young adults with cancer are falling behind
3.
Fixed-Duration Combo Shows Promise for Relapsed MCL
4.
Hospital receives 300 backpacks designed to help kids get leukemia treatment on the go
5.
A study has developed molecular markers that predict meningioma recurrence.
1.
Ultimate Guide to Oncology Services in the USA
2.
Exploring the Benefits of Teclistamab for Treating Advanced Cancer
3.
Glofitamab: A Breakthrough Therapy for Relapsed/Refractory Mantle Cell Lymphoma
4.
The Importance of Iron Rich Foods in Preventing and Treating Anemia
5.
Unexplained Weight Loss: Revealing Occult Cancers and Paraneoplastic Syndromes
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on the First Line Management of ALK+ NSCLC
2.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
4.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation